Clinical Trials Directory

Trials / Unknown

UnknownNCT03865576

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Validation of a Non-Invasive Intracranial Pressure (ICP) Device by Comparison With Implanted Intracranial Pressure Monitoring Instrumentation or Lumbar Puncture

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Boston Neurosciences · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

For purposes of validation, this study compares intracranial pressure measurements obtained with a novel self-calibrating, non-invasive, intracranial pressure measuring (ICP) device, with the values obtained from (a) patients in an intensive care unit (ICU) whose meet standard clinical indications for ICP measurement and whose ICP is measured using gold-standard implanted intracranial instrumentation and in (b) ambulatory subjects who meet clinical indications for lumbar puncture.

Detailed description

This study is designed to validate intracranial pressure measurements obtained with a novel, self-calibrating, non-invasive, intracranial pressure measuring (ICP) device based on trans-cranial Doppler technology. The ophthalmic artery is utilized as a natural ICP sensor. Up to 80 subjects will be recruited in 4 centers to achieve a power of 90% and a p\<0.05 compared to the values obtained from (a) patients in an ICU whose meet standard clinical indications for ICP measurement and whose ICP is measured using gold-standard implanted intracranial instrumentation and in (b) ambulatory subjects who meet clinical indications for lumbar puncture. At least two comparative readings, separated by an hour or more, will be obtained from each subject.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNon-invasive ICP measurementIntracranial pressure will be measured non-invasively using transorbital Doppler ultrasound. Values will be compared to ICP measured by lumbar puncture or implanted ICP sensors

Timeline

Start date
2019-03-01
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2019-03-07
Last updated
2019-03-07

Locations

4 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03865576. Inclusion in this directory is not an endorsement.